Evaxion A (EVAX) Shares Outstanding (2020 - 2025)
Evaxion A posted quarterly Shares Outstanding of $417.0 million for Q4 2025, up 494.62% year-on-year from $70.1 million in Q4 2024, and up 494.62% on a QoQ basis from $70.1 million in Q4 2024.
Evaxion A (EVAX) has 6 years of Shares Outstanding data on file, last reported at $417.0 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding rose 494.62% year-over-year to $417.0 million; the trailing twelve-month figure through Dec 2025 stood at $417.0 million (up 494.62% YoY), and the FY2025 full-year result was $417.0 million, up 494.62% from the prior year.
- Shares Outstanding for Q4 2025 stood at $417.0 million, up from $70.1 million in the prior quarter.
- Across five years, Shares Outstanding topped out at $417.0 million in Q4 2025 and bottomed at $23.2 million in Q4 2021.
- The 5-year median for Shares Outstanding is $37.9 million (2023), against an average of $114.5 million.
- The widest annual swing landed in 2022, when Shares Outstanding grew 4.03%; it then soared 494.62% in 2025.
- A 5-year view of Shares Outstanding shows it stood at $23.2 million in 2021, then increased by 4.03% to $24.1 million in 2022, then soared by 57.0% to $37.9 million in 2023, then jumped by 85.05% to $70.1 million in 2024, then jumped by 494.62% to $417.0 million in 2025.
- The last three Shares Outstanding figures came in at $417.0 million (Q4 2025), $70.1 million (Q4 2024), and $37.9 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 5.21 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 56.35 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 91.57 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 254.16 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.80 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 133.44 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 200.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 417.01 Mn |
| Dec 31, 2025 | 417.01 Mn |
| Dec 31, 2025 | 417.01 Mn |
| Dec 31, 2025 | 417.01 Mn |
| Dec 31, 2025 | 417.01 Mn |
| Dec 31, 2025 | 417.01 Mn |
| Dec 31, 2025 | 417.01 Mn |
| Dec 31, 2025 | 417.01 Mn |
| Dec 31, 2024 | 70.13 Mn |
| Dec 31, 2024 | 70.13 Mn |
| Dec 31, 2024 | 70.13 Mn |
| Dec 31, 2024 | 70.13 Mn |
| Dec 31, 2024 | 70.13 Mn |
| Dec 31, 2024 | 70.13 Mn |
| Dec 31, 2024 | 70.13 Mn |
| Dec 31, 2024 | 70.13 Mn |
| Dec 31, 2023 | 37.90 Mn |
| Dec 31, 2023 | 37.90 Mn |
| Dec 31, 2023 | 37.90 Mn |
| Dec 31, 2023 | 37.90 Mn |
| Dec 31, 2023 | 37.90 Mn |
| Dec 31, 2023 | 37.90 Mn |
| Dec 31, 2023 | 37.90 Mn |
| Dec 31, 2023 | 37.90 Mn |
| Dec 31, 2022 | 24.14 Mn |
| Dec 31, 2022 | 24.14 Mn |
| Dec 31, 2022 | 24.14 Mn |
| Dec 31, 2022 | 24.14 Mn |
| Dec 31, 2022 | 24.14 Mn |
| Dec 31, 2022 | 24.14 Mn |
| Dec 31, 2022 | 24.14 Mn |
| Dec 31, 2022 | 24.14 Mn |
| Dec 31, 2021 | 23.20 Mn |
| Dec 31, 2021 | 23.20 Mn |
| Dec 31, 2021 | 23.20 Mn |
| Dec 31, 2021 | 23.20 Mn |
| Dec 31, 2021 | 23.20 Mn |
| Dec 31, 2021 | 23.20 Mn |
| Dec 31, 2021 | 23.20 Mn |
| Dec 31, 2021 | 23.20 Mn |
| Dec 31, 2020 | 16.20 Mn |
| Dec 31, 2020 | 16.20 Mn |
| Dec 31, 2020 | 16.20 Mn |
| Dec 31, 2020 | 16.20 Mn |
| Dec 31, 2020 | 16.20 Mn |
| Dec 31, 2020 | 16.20 Mn |
| Dec 31, 2020 | 16.20 Mn |
| Dec 31, 2020 | 16.20 Mn |